Teleflex Incorporated (NYSE:TFX) Shares Purchased by Sei Investments Co.

Sei Investments Co. grew its position in shares of Teleflex Incorporated (NYSE:TFX) by 172.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 62,632 shares of the medical technology company’s stock after purchasing an additional 39,620 shares during the quarter. Sei Investments Co. owned 0.13% of Teleflex worth $13,173,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Riverview Trust Co acquired a new stake in Teleflex in the 1st quarter valued at about $31,000. Pineridge Advisors LLC acquired a new stake in Teleflex during the fourth quarter valued at approximately $35,000. Canada Pension Plan Investment Board bought a new stake in Teleflex during the second quarter worth approximately $42,000. Versant Capital Management Inc grew its position in Teleflex by 20,700.0% in the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after buying an additional 207 shares during the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of Teleflex by 78.2% in the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock valued at $48,000 after buying an additional 93 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Stephens lifted their target price on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $205.00 to $245.00 in a report on Monday, July 1st. Truist Financial raised their target price on shares of Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a report on Monday, August 5th. Finally, Royal Bank of Canada boosted their price target on shares of Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a report on Friday, August 2nd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $265.57.

Teleflex Stock Up 0.8 %

Teleflex stock opened at $246.83 on Friday. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $257.85. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58. The firm has a market cap of $11.63 billion, a PE ratio of 39.62, a P/E/G ratio of 2.23 and a beta of 1.16. The firm’s 50 day moving average price is $236.98 and its two-hundred day moving average price is $221.08.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.33 by $0.09. The business had revenue of $749.70 million during the quarter, compared to analyst estimates of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. Teleflex’s quarterly revenue was up .9% compared to the same quarter last year. During the same period last year, the company earned $3.41 earnings per share. On average, research analysts predict that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Thursday, August 15th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.55%. The ex-dividend date was Thursday, August 15th. Teleflex’s payout ratio is presently 21.83%.

Insiders Place Their Bets

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the company’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $238.93, for a total transaction of $638,898.82. Following the completion of the sale, the director now owns 5,496 shares of the company’s stock, valued at $1,313,159.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.43% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.